Who invested in Theseus Pharmaceuticals?
Theseus Pharmaceuticals's investors include OrbiMed, Foresite Capital, Omega Funds, Longitude Capital and Adage Capital Management.
One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$100Mraised across 1 round since 2021, from 1 source
Source recordedSEC filing: $22M sold, first sale Jun 2018
Theseus Pharmaceuticals's investors include OrbiMed, Foresite Capital, Omega Funds, Longitude Capital and Adage Capital Management.
Theseus Pharmaceuticals has raised $100M across 1 round since 2021.
Theseus Pharmaceuticals's most recent round was a Series B of $100M in Apr 2021.
Its most recent round, $100M in Apr 2021, is also its largest on record.
Theseus Pharmaceuticals's first round on record, in Apr 2021, was backed by OrbiMed, Foresite Capital and Omega Funds and 2 others.
Theseus Pharmaceuticals's latest named round is a Series B, in Apr 2021.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.